Applications of machine learning in drug discovery and development

By J. Vamathevan, Dominic Clark, P. Czodrowski, I. Dunham, Edgardo Ferran, George Lee, Bin Li, Anant Madabhushi, Parantu K. Shah, M. Spitzer and 1 more. Nature reviews. Drug discovery, 2019

2,480 citations recorded by the source corpus.

Drug discovery and development pipelines are long, complex and depend on numerous factors. Machine learning (ML) approaches provide a set of tools that can improve discovery and decision making for well-specified questions with abundant, high-quality data. Opportunities to apply ML occur in all stages of drug discovery. Examples include target validation, identification of prognostic biomarkers and analysis of digital pathology data in clinical trials. Applications have ranged in context and methodology, with some approaches yielding accurate predictions and insights. The challenges of applying ML lie primarily with the lack of interpretability and repeatability of ML-generated results, which may limit their application. In all areas, systematic and comprehensive high-dimensional data still need to be generated. With ongoing efforts to tackle these issues, as well as increasing awareness of the factors needed to validate ML approaches, the application of ML can promote data-driven decision making and has the potential to speed up the process and reduce failure rates in drug discovery and development. Machine learning has been applied to numerous stages in the drug discovery pipeline. Here, Vamathevan and colleagues discuss the most useful techniques and how machine learning can promote data-driven decision making in drug discovery and development. They highlight major hurdles in the field, such as the required data characteristics for applying machine learning, which will need to be solved as machine learning matures.

Subfields: Biophysics, Computational Theory and Mathematics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/b5904cd5dbf73b8d5ff13517de490c292d877ee0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biophysics

In Computational Theory and Mathematics

In Molecular Biology

Citations in the corpus

GPT (Generative Pre-Trained Transformer)— A Comprehensive Review on Enabling Technologies, Potential Applications, Emerging Challenges, and Future Directions (2023, background): “Furthermore, it has potential applications in drug discovery [85], [86], personalized medicine, patient diagnosis, medical image analysis, analyzing electronic health records, clinical decision support systems, and disease prediction.”
In silico methods and tools for drug discovery (2021, methodology): “The integration of machine learning algorithms and accumulating data may pave the new way to CADD methods [13,28].”
Artificial intelligence in drug development (2025, neutral): “As real-world and multi-omics data grow richer, utilizing advanced data mining algorithms and expert knowledge will further enhance their integration, significantly improving the success rate of target discovery. comprehensive reviews 2,24,25 .”
Machine learning applications in drug development (2019, methodology): “A variety of supervised learning methods (for instance, Support Vector Machines and Deep Learning [44–46], regression methods [47,48]) and unsupervised learning methods [13] applied to biomedical problems have been thoroughly reviewed in the last decade, with a growing interest in Deep Learning (DL)”
Computational approaches streamlining drug discovery (2023, neutral): “69–71).”
Redefining Radiology: A Review of Artificial Intelligence Integration in Medical Imaging (2023, background): “For example, AI can predict the pharmacokinetic and pharmacodynamic properties of novel compounds, pinpoint potential drug targets, and simulate clinical trials, substantially reducing both time and costs associated with drug development [51].”
A review on machine learning approaches and trends in drug discovery (2021, background): “Tofacilitate this understanding, works such as [18,19] provide an overview of machine learning techniques and the current state of applications for drug discovery in both academic and industrial settings.”
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies (2022, background): “One of the key challenges is the availability of suitable data [40].”
Artificial intelligence in cancer target identification and drug discovery (2022, background): “The third challenge is hard to provide interpretability of deep learning models 185 .”
Machine learning and deep learning approach for medical image analysis: diagnosis to detection (2022, background): “ML is a branch of AI where a machine learns from the data by identifying patterns and automates decision-making with minimum human intervention [96, 24, 12].”
Automated Machine Learning: From Principles to Practices (2018, background): “Its primary objective is the automated determination of optimal learning configurations tailored to a given machine learning task.”
Artificial intelligence for digital and computational pathology (2023, background): “5) and translational considerations for clinical deployment (Box 3).”
Artificial intelligence to deep learning: machine intelligence approach for drug discovery (2021, background): “In addition to that, very less drug discovery data are available to train AI models [448].”
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design (2023, background): “Dimensionality reduction can be applied to various types of pharmaceutical data, including gene expression data, drug activity profiles, or imaging data [47].”